Imperial College London

Dr. David James PINATO

Faculty of MedicineDepartment of Surgery & Cancer

Clinical Reader in Medical Oncology
 
 
 
//

Contact

 

+44 (0)20 7594 2799david.pinato Website

 
 
//

Location

 

ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Fulgenzi:2022:10.1080/13543784.2022.2072726,
author = {Fulgenzi, CAM and D'Alessio, A and Ogunbiyi, O and Demirtas, CO and Gennari, A and Cortellini, A and Sharma, R and Pinato, DJ},
doi = {10.1080/13543784.2022.2072726},
journal = {EXPERT OPINION ON INVESTIGATIONAL DRUGS},
pages = {681--691},
title = {Novel immunotherapy combinations in clinical trials for hepatocellular carcinoma: will they shape the future treatment landscape?},
url = {http://dx.doi.org/10.1080/13543784.2022.2072726},
volume = {31},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Fulgenzi,CAM
AU - D'Alessio,A
AU - Ogunbiyi,O
AU - Demirtas,CO
AU - Gennari,A
AU - Cortellini,A
AU - Sharma,R
AU - Pinato,DJ
DO - 10.1080/13543784.2022.2072726
EP - 691
PY - 2022///
SN - 1354-3784
SP - 681
TI - Novel immunotherapy combinations in clinical trials for hepatocellular carcinoma: will they shape the future treatment landscape?
T2 - EXPERT OPINION ON INVESTIGATIONAL DRUGS
UR - http://dx.doi.org/10.1080/13543784.2022.2072726
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000791900900001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 31
ER -